Title : Clinical pharmacokinetics of darunavir.

Pub. Date : 2007

PMID : 17713972






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Coadministration with small doses of the strong CYP3A4 inhibitor ritonavir results in an increase in darunavir bioavailability from 37% to 82%. Darunavir cytochrome P450 family 3 subfamily A member 4 Homo sapiens
2 With regard to the necessary coadministration with low-dose ritonavir as a potent CYP3A4 inhibitor, coadministration of other substrates of CYP3A4 with darunavir/ritonavir requires caution or is even contraindicated. Darunavir cytochrome P450 family 3 subfamily A member 4 Homo sapiens